Biblio Discovery — Demo Discovery Service

7 results for "Meera Muthukrishnan"

Showing 1–7 · 0.66 seconds · RSS

  1. Journal Article

    Patients' self-reported barriers to colon cancer screening in federally qualified health center settings

    Meera Muthukrishnan; Lauren D. Arnold; Aimee S. James

    Preventive Medicine Reports, Vol. 15 · 2019 · English · DOAJ Scopus

    Colorectal cancer (CRC) is a leading cause of cancer-related death in the United States. Despite evidence that screening reduces CRC incidence and mortality, only about 60% of age-eligible adults are up-to-date on CRC screening. This analysis aims to identify self-reported barriers to CRC screening…

  2. Journal Article

    Evaluating a community academic partnership to advance equity-focused cancer genetic implementation research: a qualitative analysis of partner perspectives

    Ariana Naaseh; Meera Muthukrishnan; Isabel Temosihue et al.

    Frontiers in Public Health, Vol. 13 · 2025 · English · DOAJ Scopus

    BackgroundForming community academic partnerships (CAPs) can increase the applicability, translation, and dissemination of implementation research focused on addressing health inequities within the community setting. We aimed to explore community and academic partners’ perspectives on their…

  3. Journal Article

    Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18–35

    Meera Muthukrishnan; Travis Loux; Enbal Shacham et al.

    Preventive Medicine Reports, Vol. 29 · 2022 · English · DOAJ Scopus

    In the United States (US), an estimated 35,900 human papillomavirus (HPV)-related cancers are diagnosed annually. HPV vaccines are projected to eliminate ∼90% of these cancers. Routine vaccination is recommended at age 11–12 with “catch-up” vaccination through age 26 and shared clinical decision…

  4. Journal Article

    Conducting a randomized trial in rural and urban safety-net health centers: Added value of community-based participatory research

    Meera Muthukrishnan; Siobhan Sutcliffe; Jean M. Hunleth et al.

    Contemporary Clinical Trials Communications, Vol. 10 · 2018 · English · DOAJ Scopus

    Background: Colorectal cancer (CRC) is the second most common cancer in the US. Despite evidence that screening reduces CRC incidence and mortality, screening rates are sub-optimal with disparities by race/ethnicity, income, and geography. Rural-urban differences in CRC screening are understudied…

  5. Journal Article

    Correlates of human papillomavirus (HPV) vaccination initiation and completion among 18–26 year olds in the United States

    Eric Adjei Boakye; Daphne Lew; Meera Muthukrishnan et al.

    Human Vaccines & Immunotherapeutics, Vol. 14 No. 8 · 2018 · English · DOAJ Scopus

    Purpose: To examine correlates of HPV vaccination uptake in a nationally representative sample of 18–26-year-old adults. Methods: Young adults aged 18–26 years were identified from the 2014 and 2015 National Health Interview Survey (n = 7588). Survey-weighted multivariable logistic regression…

  6. Journal Article

    Improving Communication and Management Following a Positive Home HPV Self-Sampling Result: Comparing Intervention Strategies Between the HOME and STEP Trials

    Jasmin A. Tiro; Meera Muthukrishnan; Sadie Metcalfe et al.

    Women's Health Reports, Vol. 6 No. 1 · 2025 · English · DOAJ Scopus

    Background: Mailed human papillomavirus (HPV) self-sampling kits improve cervical cancer screening adherence. The HOME trial found information needs and anxiety among HPV-positive patients. We designed a STEP trial to test optimized intervention strategies with bolstered educational materials and a…

  7. Journal Article

    Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel program

    Chika Nwachukwu; Sukh Makhnoon; Marieshia Person et al.

    Contemporary Clinical Trials Communications, Vol. 39 · 2024 · English · DOAJ Scopus

    Involving diverse populations in early-phase (phase I and II) cancer clinical trials is critical to informed therapeutic development. However, given the growing costs and complexities of early-phase trials, trial activation and enrollment barriers may be greatest for these studies at healthcare…